Mercury exposure: Evaluation and intervention - The inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning

被引:115
作者
Risher, JF
Amler, SN
机构
[1] Agcy Tox Subst & Dis Registry, Div Toxicol F32, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA
关键词
metallic mercury; mercury poisoning; chelation;
D O I
10.1016/j.neuro.2005.05.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Public awareness of the potential for mercury to cause health problems has increased dramatically in the last 15 years. It is now widely recognized that significant exposure to all forms of mercury (elemental/metallic and both inorganic and organic compounds) can result in a variety of adverse health effects, including neurological, renal, respiratory, immune, dermatologic, reproductive, and developmental sequellae. And while the various media have made the general population cognizant of the need to avoid unnecessary exposure to this naturally occurring element, there has also evolved a growing tendency to attribute unexplainable neurologic, as well as other signs and symptoms to mercury, whether or not significant exposure to mercury has actually occurred. For the physician, making a diagnosis of mercury intoxication can be difficult, because many of the clinical signs and symptoms of mercury exposure can also be attributed to any number of causes, including undiagnosed neurological diseases, pharmacotherapy, vitamin or mineral deficiencies, and psychological stress. The physician must be able to recognize the clinical manifestations of mercury intoxication, and understand the importance of biological markers in making a definitive diagnosis of mercury poisoning. In a desire to treat the patient complaining of symptoms similar to some that can be caused by mercury, a growing number of physicians, particularly those in alternative medicine fields, result to chelation to "rid" the body of the mercury believed to be the cause of the ailments. And although the use of chelation is increasing, controlled studies showing that this procedure actually improves outcome are lacking. If chelation therapy is considered to be indicated, the attending physician should communicate the risks of chelation to the patient before beginning treatment with metal-chelating drugs. (c) 2005 Published by Elsevier Inc.
引用
收藏
页码:691 / 699
页数:9
相关论文
共 67 条
[41]  
MADHOK M, 1997, ELEMENTAL MERCURY HG, P520
[42]  
MANN KV, 1991, CLIN PHARMACY, V10, P914
[43]   CHRONIC MERCURY-POISONING FROM A SINGLE BRIEF EXPOSURE [J].
MCFARLAND, RB ;
REIGEL, H .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1978, 20 (08) :532-534
[44]  
MCFEE RB, 2001, CLIN TOXICOL, P733
[45]  
MCKAY CA, 2003, INT J MED TOXICOL, V6, P1
[46]  
*MED EC COMP, 2001, PDR PHYS DESK REF, P2850
[47]  
MOEL DI, 1982, PEDIATRICS, V70, P259
[48]   Evoked potentials in Faroese children prenatally exposed to methylmercury [J].
Murata, K ;
Weihe, P ;
Araki, S ;
Budtz-Jorgensen, E ;
Grandjean, P .
NEUROTOXICOLOGY AND TERATOLOGY, 1999, 21 (04) :471-472
[49]   Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury [J].
Murata, K ;
Weihe, P ;
Budtz-Jorgensen, E ;
Jorgensen, PJ ;
Grandjean, P .
JOURNAL OF PEDIATRICS, 2004, 144 (02) :177-183
[50]   Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study [J].
Myers, GJ ;
Davidson, PW ;
Cox, C ;
Shamlaye, CF ;
Palumbo, D ;
Cernichiari, E ;
Sloane-Reeves, J ;
Wilding, GE ;
Kost, J ;
Huang, LS ;
Clarkson, TW .
LANCET, 2003, 361 (9370) :1686-1692